Breast cancer in situ – Life with Disease

Go back

Breast cancer in situ, also called ductal carcinoma in situ or DCIS, represents the earliest form of breast cancer where abnormal cells remain confined within the milk ducts and have not spread into surrounding breast tissue. While receiving this diagnosis can feel overwhelming, it’s important to understand that this condition is highly treatable and has an excellent outlook when properly addressed.

Prognosis

If you have been diagnosed with breast cancer in situ, it’s natural to feel worried about what lies ahead. However, the outlook for this condition is remarkably positive, and this information should provide some reassurance during this difficult time. The 10-year survival rate for people diagnosed with DCIS is approximately 98%, regardless of whether they receive treatment beyond surgery[13]. This means that practically all patients with this stage of breast cancer can be cured[6].

Because DCIS is considered stage 0 breast cancer, the cancer cells have not invaded the surrounding breast tissue or spread to other parts of the body. This containment within the milk ducts means the condition is highly treatable, and the prognosis is excellent[5]. The main goal of treatment is not necessarily to improve survival, since survival rates are already very high, but rather to prevent the condition from potentially developing into invasive breast cancer in the future.

It’s important to understand that while DCIS itself is not life-threatening, it does require evaluation and consideration of treatment options[1]. Your healthcare team will work with you to develop a treatment plan that takes into account the characteristics of your specific case, including the grade of the cells, the size of the affected area, and your personal preferences and circumstances.

Natural Progression

Understanding what might happen if breast cancer in situ is left untreated can help you make informed decisions about your care. Without treatment, there is a possibility that DCIS could progress to invasive breast cancer over time. Research suggests that somewhere between 10% and 50% of DCIS cases may develop into invasive breast cancer if not treated[16], though more recent modeling studies suggest the range could be even wider, from 36% to 100% of cases[8].

The challenge healthcare providers face is that they cannot currently predict which cases will progress to invasive cancer and which will remain unchanged[16]. This uncertainty is one of the main reasons why almost all cases of DCIS are treated. When cells remain confined to the milk ducts, they cannot spread to other parts of the body. However, if these abnormal cells break through the walls of the milk ducts and spread into the surrounding breast tissue, the cancer becomes invasive[5].

The time frame for potential progression varies considerably. Some research models suggest that progression from DCIS to invasive breast cancer, when it occurs, typically takes between 0.2 to 2.5 years[8]. The grade of DCIS plays a role in this progression risk. High-grade DCIS, where cells look very abnormal under a microscope and grow more quickly, is thought to be more likely to develop into invasive cancer compared to low-grade DCIS[2].

⚠️ Important
While DCIS is considered noninvasive and pre-invasive breast cancer, it is not the same as invasive breast cancer. In invasive breast cancer, cancer cells have broken out of the ducts and spread into surrounding breast tissue, which means there is a chance they can spread to nearby lymph nodes or other parts of the body. Because healthcare providers cannot predict which DCIS cases will progress, treatment is almost always recommended.

Possible Complications

The most significant complication associated with breast cancer in situ is its potential transformation into invasive ductal carcinoma if left untreated[5]. This transformation represents a major change in the nature of the disease, as invasive cancer has the ability to spread beyond the breast to lymph nodes and other organs in the body. This is why timely treatment is so important.

After receiving treatment for DCIS, there is a possibility of recurrence, meaning the abnormal cells could return. The cancer can come back either as DCIS again or as invasive breast cancer. Treatment with surgery alone, or surgery combined with radiation therapy or hormone therapy, aims to reduce this risk of recurrence. For example, radiation therapy after breast-conserving surgery can cut the risk of recurrence by about half, while hormone therapy can reduce it by about a quarter[13].

If you have been treated for DCIS, you face a higher risk of developing certain health conditions as you age. These may include osteoporosis (a condition where bones become weak and brittle), high blood pressure, and heart disease[5]. These risks highlight the importance of ongoing medical follow-up even after successful treatment. Regular screenings and monitoring can help detect these conditions early when they are most manageable.

Some treatments for DCIS can also cause side effects that, while not life-threatening, can affect your quality of life. For instance, if lymph nodes are removed during surgery, there is a risk of developing lymphedema, which is swelling in the arm caused by a buildup of lymph fluid. Radiation therapy can cause skin changes and fatigue. These potential complications should be discussed with your healthcare team so you can weigh the benefits and risks of different treatment approaches.

Impact on Daily Life

A diagnosis of breast cancer in situ can affect many aspects of your daily life, from your physical health to your emotional well-being, relationships, work, and leisure activities. Understanding these potential impacts can help you prepare and find ways to cope during treatment and recovery.

Physically, the treatments for DCIS can temporarily limit your activities. Surgery, whether it’s a lumpectomy (removal of the tumor and some surrounding tissue) or mastectomy (removal of the entire breast), requires recovery time during which you may need to limit arm movements and avoid heavy lifting. If you undergo radiation therapy, you may experience fatigue that makes it harder to keep up with your usual routine. The treatment typically lasts three to four weeks, during which you’ll need to attend daily sessions[13].

Emotionally, dealing with a cancer diagnosis is challenging, even when the prognosis is excellent. Many people experience anxiety, fear, and uncertainty about the future. You might worry about the possibility of recurrence or about how treatment will affect your body image, especially if you’re considering mastectomy. These feelings are completely normal and valid. Some women find that participating in support groups, talking with a counselor, or connecting with others who have been through similar experiences helps them cope.

Your relationships with family and friends may be affected as well. Loved ones may want to help but might not know how, or you might find it difficult to communicate your needs and feelings. Being open about what you’re going through and what kind of support would be helpful can strengthen these relationships. On the other hand, some people may struggle to understand that while DCIS is serious, it’s also highly curable, which can create tension or miscommunication.

Work and financial considerations are also important. You may need to take time off for surgery and recovery, and if you’re receiving radiation therapy, you’ll need to schedule regular appointments. Some employers are very understanding and accommodating, while others may be less flexible. If you’re self-employed or don’t have paid sick leave, the financial impact of treatment can add stress to an already difficult situation. Speaking with a social worker or patient navigator at your treatment facility can help you explore options for financial assistance or workplace accommodations.

Many people find that hobbies and activities they once enjoyed are temporarily affected during treatment and recovery. Physical activities may be limited after surgery, and fatigue from radiation can make it harder to engage in social activities or pursue interests. However, most people are able to gradually return to their normal activities as they recover. Some individuals actually find new interests or prioritize activities differently after going through treatment, focusing more on what brings them joy and fulfillment.

Support for Family

When someone is diagnosed with breast cancer in situ, it affects not just the patient but their entire family. Family members and close friends play a crucial role in providing support throughout the diagnosis, treatment, and recovery process. Understanding how to help can make a significant difference in the patient’s experience and outcomes.

One of the most important things family members can do is educate themselves about DCIS. Understanding that this is a highly treatable condition with an excellent prognosis can help alleviate some of the fear and anxiety that comes with hearing the word “cancer.” At the same time, it’s important to recognize that even though DCIS has a good outlook, it’s still a serious diagnosis that requires treatment and can be emotionally difficult for the person going through it.

Practical support is invaluable during treatment. This might include driving the patient to medical appointments, helping with household chores, preparing meals, or caring for children. After surgery, the patient may have restrictions on lifting and arm movements, so assistance with daily tasks becomes especially important. Sometimes the most helpful thing is simply being present and available, whether that means sitting in the waiting room during appointments or just spending quiet time together.

Emotional support is equally crucial. Listening without judgment, allowing the patient to express fears and concerns, and offering reassurance can help ease the emotional burden. However, it’s important to let the patient take the lead in conversations about their diagnosis and treatment. Some people want to talk about it extensively, while others prefer to focus on other topics. Respecting their preferences and following their cues helps them feel supported without being overwhelmed.

If clinical trials are being considered as part of treatment, family members can help by researching trial options, asking questions about what participation would involve, and helping the patient weigh the potential benefits and risks. Clinical trials can offer access to innovative treatments and contribute to advancing medical knowledge, but they’re not right for everyone. Family members can assist by gathering information from healthcare providers about available trials, helping to understand eligibility requirements, and discussing how trial participation might affect daily life and treatment schedules.

It’s also important for family members to take care of themselves during this time. Supporting someone through cancer treatment can be emotionally and physically draining. Seeking support from friends, joining a caregiver support group, or talking with a counselor can help family members manage their own stress and maintain their ability to provide support. Remember that taking care of yourself isn’t selfish—it’s necessary to be able to effectively support your loved one.

⚠️ Important
Family members should be aware that their loved one may experience a range of emotions throughout treatment and recovery, including fear, anger, sadness, and even guilt. These emotional responses are normal and don’t mean that the patient isn’t coping well. Creating a safe space for expressing these feelings without trying to “fix” them or minimize their concerns is one of the most valuable forms of support you can provide.

Ongoing Clinical Trials on Breast cancer in situ

  • Study on Breast Cancer Prevention in High-Risk Women Using Low Dose Tamoxifen and Lifestyle Changes

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

References

https://www.mayoclinic.org/diseases-conditions/dcis/symptoms-causes/syc-20371889

https://www.cancerresearchuk.org/about-cancer/breast-cancer/types/ductal-carcinoma-in-situ-dcis

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-carcinoma-in-situ

https://www.nationalbreastcancer.org/dcis/

https://my.clevelandclinic.org/health/diseases/17869-ductal-carcinoma-in-situ-dcis

https://www.bcrf.org/about-breast-cancer/dcis-ductal-carcinoma-in-situ/

https://www.cancer.org/cancer/types/breast-cancer/treatment/treatment-of-breast-cancer-by-stage/treatment-of-ductal-carcinoma-in-situ-dcis.html

https://www.ncbi.nlm.nih.gov/books/NBK567766/

https://www.cancer.org/cancer/types/breast-cancer/treatment/treatment-of-breast-cancer-by-stage/treatment-of-ductal-carcinoma-in-situ-dcis.html

https://www.mayoclinic.org/diseases-conditions/dcis/diagnosis-treatment/drc-20371895

https://www.mskcc.org/news/what-ductal-carcinoma-situ-dcis-and-how-do-decide-right-treatment

https://www.ncbi.nlm.nih.gov/books/NBK567766/

https://www.cuimc.columbia.edu/news/stage-zero-breast-cancer-whats-optimal-treatment-dcis

https://www.mdanderson.org/cancerwise/ductal-carcinoma-in-situ–dcis—7-things-to-know.h00-159616278.html

https://www.nationalbreastcancer.org/dcis/

https://www.komen.org/breast-cancer/treatment/by-diagnosis/dcis/

https://www.nationalbreastcancer.org/breast-cancer-stage-0/

https://www.premiersurgicalnetwork.com/blog/navigating-life-after-breast-cancer-diagnosis?utm_source=loclisting&utm_medium=Organic&utm_campaign=directory-appt&utm_content=PSNPA&rsiCampaignId=43255

https://www.bcrf.org/about-breast-cancer/dcis-ductal-carcinoma-in-situ/

https://www.lbbc.org/your-journey/recently-diagnosed

https://www.breastcancer.org/personal-stories/what-breast-cancer-has-taught-me

FAQ

Is breast cancer in situ the same as invasive breast cancer?

No, breast cancer in situ (DCIS) and invasive breast cancer are not the same. With DCIS, the abnormal cells remain confined within the milk ducts and have not broken through the duct walls to spread into surrounding breast tissue. Invasive breast cancer means the cancer cells have spread beyond the ducts into the breast tissue, and potentially to lymph nodes or other parts of the body.

Will I need chemotherapy for breast cancer in situ?

Chemotherapy is typically not used to treat DCIS. The main treatment is usually surgery (either lumpectomy or mastectomy), which may be followed by radiation therapy or hormone therapy depending on the characteristics of your case. Treatment decisions are made based on factors such as the size and grade of the DCIS, whether it was completely removed during surgery, and your individual circumstances.

What is the difference between high-grade and low-grade DCIS?

The grade of DCIS refers to how abnormal the cells look under a microscope. Low-grade DCIS cells look more like normal cells and tend to grow more slowly, while high-grade DCIS cells look very abnormal and grow more quickly. High-grade DCIS is considered more likely to come back after treatment or to potentially spread into surrounding breast tissue compared to low-grade DCIS.

Can breast cancer in situ come back after treatment?

Yes, there is a possibility of recurrence after treatment for DCIS. The cancer can return either as DCIS again or as invasive breast cancer. Treatment with surgery, sometimes combined with radiation therapy or hormone therapy, is designed to reduce this risk. Radiation therapy can reduce the risk of recurrence by about half, and hormone therapy can reduce it by approximately a quarter.

How is breast cancer in situ usually detected?

Most cases of DCIS are detected during routine mammogram screening. On a mammogram, DCIS typically appears as tiny flecks of calcium in the breast tissue, called calcifications or calcium deposits. Most people with DCIS don’t have any noticeable symptoms, though a small number may notice a breast lump, itchy skin, or nipple discharge that might be blood-stained.

🎯 Key takeaways

  • Breast cancer in situ (DCIS) has a 10-year survival rate of approximately 98%, making it one of the most treatable forms of breast cancer.
  • DCIS is called “stage 0” breast cancer because the abnormal cells remain confined within the milk ducts and have not invaded surrounding tissue.
  • Over 90% of DCIS cases are discovered during routine mammogram screening, often before any symptoms appear.
  • Without treatment, between 10% and 50% of DCIS cases may develop into invasive breast cancer, though doctors cannot predict which cases will progress.
  • The main treatment is surgery (lumpectomy or mastectomy), which may be followed by radiation therapy or hormone therapy depending on individual circumstances.
  • High-grade DCIS, where cells look very abnormal and grow quickly, is more likely to recur or become invasive compared to low-grade DCIS.
  • Family history, genetic mutations (BRCA1 and BRCA2), dense breast tissue, and starting menstruation before age 12 are among the risk factors for DCIS.
  • While DCIS is not life-threatening, people treated for it have a higher risk of developing osteoporosis, high blood pressure, and heart disease as they age, making ongoing medical follow-up important.